Health care legislation organization Frier Levitt has analyzed FDA enforcement steps versus “investigate only” peptide sellers. Their conclusion: the FDA considers an item’s classification dependant on its supposed use, not its disclaimers. When Web sites contain dosage guides, reconstitution Directions, or url to message boards talking about